Literature DB >> 6322675

Influence of food on the pharmacokinetics of ketoconazole.

T K Daneshmend, D W Warnock, M D Ene, E M Johnson, M R Potten, M D Richardson, P J Williamson.   

Abstract

Eight healthy adults were given single oral doses of ketoconazole (200, 400, 600, and 800 mg) in the fasting state and with a standard breakfast at weekly intervals according to a balanced block design. Concentrations in serum were measured up to 32 h after the dose. Food did not reduce ketoconazole absorption or significantly alter peak ketoconazole concentrations in serum, though there was a food-related delay in achieving peak concentrations. At the 400- and 600-mg doses, food appeared to enhance absorption, but this effect was not seen at the 800-mg dose. With an increase in dose, the half-life and area under the serum concentration-time curve increased disproportionately, suggesting that the pharmacokinetics of ketoconazole may be dose dependent. Up to the 800-mg dose, the elimination of ketoconazole did not appear to be saturable. Administration of the drug with food is unlikely to be a cause of therapeutic failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322675      PMCID: PMC185421          DOI: 10.1128/AAC.25.1.1

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

2.  Pharmacokinetics of ketoconazole in normal subjects.

Authors:  T K Daneshmend; D W Warnock; A Turner; C J Roberts
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

Review 3.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  Pharmacokinetics of ketoconazole in patients with neoplastic diseases.

Authors:  A W Maksymiuk; H B Levine; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

5.  The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

6.  Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.

Authors:  W E Dismukes; A M Stamm; J R Graybill; P C Craven; D A Stevens; R L Stiller; G A Sarosi; G Medoff; C R Gregg; H A Gallis; B T Fields; R L Marier; T A Kerkering; L G Kaplowitz; G Cloud; C Bowles; S Shadomy
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

7.  High-dose ketoconazole for treatment of fungal infections of the central nervous system.

Authors:  P C Craven; J R Graybill; J H Jorgensen; W E Dismukes; B E Levine
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

8.  Disposition of ketoconazole, an oral antifungal, in humans.

Authors:  C Brass; J N Galgiani; T F Blaschke; R Defelice; R A O'Reilly; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Impairing effect of food on ketoconazole absorption.

Authors:  P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu; P Ottoila
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

10.  Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.

Authors:  D Borelli; J L Bran; J Fuentes; R Legendre; E Leiderman; H B Levine; A Restrepo; D A Stevens
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

View more
  33 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers.

Authors:  Varun Garg; Gurudatt Chandorkar; Yijun Yang; Nathalie Adda; Lindsay McNair; Katia Alves; Frances Smith; Rolf P G van Heeswijk
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

3.  Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Authors:  Hayley S Brown; Kiyomi Ito; Aleksandra Galetin; J Brian Houston
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

4.  Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

Authors:  Hannah M Jones; Neil Parrott; Gerd Ohlenbusch; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  A Bayesian meta-analysis on published sample mean and variance pharmacokinetic data with application to drug-drug interaction prediction.

Authors:  Menggang Yu; Seongho Kim; Zhiping Wang; Stephen Hall; Lang Li
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

6.  Diseases and drugs but not food decrease ketoconazole 'bioavailability'.

Authors:  T K Daneshmend
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

7.  Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.

Authors:  Neil Mathias; Yan Xu; Balvinder Vig; Umesh Kestur; Amy Saari; John Crison; Divyakant Desai; Aditya Vanarase; Munir Hussain
Journal:  AAPS J       Date:  2015-05-02       Impact factor: 4.009

Review 8.  The role of diet on the clinical pharmacology of oral antineoplastic agents.

Authors:  Antonio Ruggiero; Maria G Cefalo; Paola Coccia; Stefano Mastrangelo; Palma Maurizi; Riccardo Riccardi
Journal:  Eur J Clin Pharmacol       Date:  2011-07-28       Impact factor: 2.953

9.  The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.

Authors:  J J Miceli; M Smith; L Robarge; T Morse; A Laurent
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

10.  Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.

Authors:  Gopal Krishna; Allen Moton; Lei Ma; Matthew M Medlock; James McLeod
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.